B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
about
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.A New Kid on the Block: IL-10+ Regulatory B Cells and a Possible Role In Psoriasis.Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine responseIdiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choicesUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.How do follicular dendritic cells interact intimately with B cells in the germinal centre?Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Current imaging strategies in rheumatoid arthritisExpression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study.B cell modulation in rheumatologyRefractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.Management of antiphospholipid syndrome
P2860
Q30985481-E6D91A97-A623-4EB7-984A-5100A7DD7D33Q33403761-30DE723F-F886-4F17-BD0E-021298A66E32Q35087990-82774896-C270-4A90-B10A-A2B250204F28Q35151856-43DEE381-6E71-4E9E-B05C-F90EBAE62B7EQ35638252-275E2B27-0844-4041-AE84-D1CB4590A6CDQ35988025-51AE5A03-5D05-4C63-BB62-AC5D681DB388Q36171750-D86DB679-230C-419A-89E3-96AA99012E87Q36337258-C5AE78BF-5291-4739-B41E-E6368624F2F7Q36402809-44825D44-1FDB-417E-934B-85B4408C13A0Q36878215-12EAF812-0178-48D2-A587-7464694C0AD9Q37344993-1BDEA257-C713-426E-896A-A2E586F8D98CQ38311906-49FE98FF-08A0-4959-A7C8-3E3B441897DCQ40454662-A91119BE-CD8D-4523-A58B-8EF8BF374E81Q42955604-DEFD793B-0AB3-4341-9F79-8B001F780685Q47277628-3ABF2D4D-22E3-4917-A32B-869AB3D0AE38Q57656275-4B6BE632-2B64-46A2-BAC6-8B0E26EBB66D
P2860
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@ast
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@en
type
label
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@ast
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@en
prefLabel
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@ast
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@en
P2093
P2860
P1476
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
@en
P2093
P2860
P304
P407
P478
62 Suppl 2
P577
2003-11-01T00:00:00Z